For the DSM-V Task Force, being greasy never been so easy!

von freakoutcrazy

by Altmentalities

It’s not easy to balance a private medical practice, pharmaceutical company-sponsored lecture tours or research projects, and the invention of new psychiatric diagnoses… but at least 68% of the DSM-V Task Force is doing it! Yup; 68% of them openly report financial ties to the pharmaceutical industry (that’s up from the last time around, when 56% of the DSM-IV Task Force reported financial ties to pharma).*

It’s the Conflict of Interest Championships!

The DSM-V task force is divided into 13 work groups: ADHD, Anxiety, Child-Adolescence, Eating, Mood, Neurocognitive, Neurodevelopmental, Personality, Psychosis, Sexual-GID, Sleep-Wake, Somatic Distress, and Substance-Related. [They’re wild about hyphens over at the APA…] Each task force has 8-12 members, and each one of those members is required to disclose all ties to industry, professional organizations, and any other conflicts of interest [COI].

So here’s a fun game: go to the APA’s “Meet the Work Groups” web page, pick your favorite task force, and do a little investigating. How many members have financial ties to the pharmaceutical industry? And what kind of ties… is their research funded by pharma? Are they being paid for the use of their “expert opinion” in drug advertisements? Or is it an out-and-out bribe?

I’ve been playing the game all morning. Here’s the score:

Psychotic Disorders Work Group

80% (8 of 10 reporting members) have direct financial ties to the pharmaceutical industry.

4 of those 8 receive it in the form of what I like to call “free money” – they simply stand in front of a pharmaceutical company-designed powerpoint or give their name to a ghostwritten scholarly article, lending it an air of crediblity, and win a cash prize! It’s called “honroraria,” “consultation,” or sometimes just “other” in the COI disclosures published on the APA’s website.

All Star Member: Wolfgang Gaebel, Professor Dr. med., M.D.

9 reported ties to pharmaceutical companies, including: Astra-Zeneca, Bristol-Myers Squibb, Lilly, Janssen-Cilag, Novartis, and Wyeth.

Coincidentally [or not], the makers of the 5 most commonly prescribed atypical antipsychotic medications** — in order… Astra-Zeneca (Seroquel), Janssen-Cilag (Risperdal),Bristol-Myers Squibb (Abilify), Lilly (Zyprexa), Pfizer (Geodon) — have ALL sponsored one or more members of the Psychotic Disorders Work Group.
ADHD Work Group

57% (4 of 7 reporting members) have direct financial ties to the pharmaceutical industry.

All 4 are receiving “free money.”

All Star Member: Rosemary Tannock, Ph.D.

8 reported ties to pharmaceutical companies, including: Pfizer, Lilly, and McNeil. She also helped make an “informational” video about ADHD for teachers. Great.

Mood Disorders Work Group

56% (5 of 9 reporting members) have direct financial ties to the pharmaceutical industry.

All 5 receiving “free money.”

All Star Member: Trisha Suppes, M.D.

46 reported ties to pharmaceutical companies including: Abbot Laboratories, Astra-Zeneca, GlaxoSmithKline, JDS Pharmaceuticals, Janssen, Lilly, Novartis, Pfizer, and Wyeth. And she’s a professor at Stanford to boot! She might just be our league MVP.

Again, this strange coincidence: The makers of the 5 most commonly prescribed antidepressants – in order… Zoloft (Pfizer), Prozac (Lilly), Cymbalta (Lilly), Effexor (Pfizer), and Wellbutrin (GlaxoSmithKline) – are all contributing to the various bank accounts of our Mood Disorders Work Group workers.

The makers of 3 common “mood stabilizer” medications — Abbot Laboratories (Depakote), GlaxoSmithKline (Lamictal), Pfizer (Gabapentin) — are doing the same.

And our All Star, Trisha Suppes, represents the makers of ALL of these drugs, by herself!

Looks like greasy goes down real easy with her.
Anxiety Disorders Work Group

56% (5 of 9 reporting members) have direct financial ties to the pharmaceutical industry.

All 5 receiving “free money.”

All Star Member: Murray B. Stein, M.D., M.P.H., FRCPCC [they should have him guest star on Sesame Street!]

12 reported ties to pharmaceutical companies including:Forest, GSK, Astra-Zeneca, Lilly, Bristol-Myers Squibb, Johnson & Johnson, and Avera. Plenty of free money to be had from these folks!

Now you know what I’m going to say; the makers of drugs commonly prescribed to patients labeled in this category are well represented in those COI statements released by the Anxiety Disorders Work Group.

“But we thought the more hyphens and COI disclosures, the better!”

Sorry, APA. I don’t think you guys get it.

Let me make it real simple:
Hyphens for the sake of hyphens don’t make you look smart, and COI disclosures made with no fear of penalty or reprimand don’t make you look ethical.

The whole point of disclosing conflicts of interest is determining whether someone is unencumbered enough to participate in a decision-making/fact-finding process. So when Trisha Suppes says, “I have 46 financial ties to pharmaceutical companies, many of whom are trying to sell drugs to the people I’m trying to label,” … that should raise some red flags. She should not be included in the Mood Disorders Work Group, because she is clearly NOT capable of making unbiased contributions.
Indigestion…

With this level of greasiness going down, you guys are in for some serious indigestion. But, hey, don’t worry — there’s a pill for that!

*The figures for the DSM-V Task Force come from this article; for the DSM-IV, they come from here.

**As of 2009, according to this ranking. It appears to be the most recent ranking available. I’ve used it for all subsequent classes of drugs, as well.

Quelle

Advertisements